Effects of CLA Supplements on Body Weight and Fat Oxidation
Obesity
About this trial
This is an interventional treatment trial for Obesity
Eligibility Criteria
Inclusion Criteria: BMI 25-29.9 kg/m2 Absence of a weight change of greater than 3 kg in the previous 6 months Exclusion Criteria: Presence of a physical limitation to walking exercise Current or recent (6 months) enrollment in a commercial or self-prescribed weight loss program A history of metabolic disease-ie. renal, endocrine, hepatic or gastrointestinal disease that would impact the outcome of the study A history of a psychiatric or eating disorders Ÿ Presence of metal implants that would interfere with body composition analysis Fasting plasma cholesterol >300mg/dl or triglycerides above 500 mg/dl. Abnormal EKG
Sites / Locations
- University of Wisconsin
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
CLA treatment
Placebo
The group randomized to Conjugated Linoleic Acid (CLA) treatment at 4 grams per day of 39% cis-9, trans-11 CLA; 39% trans-10, cis-12 CLA; and 22% safflower oil for 6 months
The group randomized to control received 4 g/d of safflower oil.